Found: 1
Select item for more details and to access through your institution.
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 622, doi. 10.1007/s10637-022-01235-5
- By:
- Publication type:
- Article